MRPL9 and hepatocellular carcinoma: In lung cancer and hepatocellular carcinoma, MRPL9 overexpression is associated with poor survival and recurrence, and knockdown in an in vitro cell model inhibited pro-metastatic capabilities such as migration, spheroid formation, and proliferation [49, 50].